Skip to main content

Roche’s Analyst Event from SABCS 2019

Roche has hosted a live audio webcast on Monday, 16 December 2019

agenda
Agenda:
Welcome Karl Mahler, Head of Investor Relations
HER2+ Franchise OverviewAlan Sandler, Sr. Vice President, Global Head of Oncology Product Development - Solid Tumors
HR+ and TNBC Franchise OverviewElena Bernedo Arzac, Sr. Vice President, Head of Oncology Global Product Strategy
Key Early Stage Data Presented at SABCS (GDC-0077 and GDC-9545)Stuart Lutzker, Vice President BioOncology, gRED Early Clinical Development
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Related links

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Roche’s Annual Report 2018

    Investors

    How digital innovation increases patient benefit in the future.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions